A small fraction of unresectable colorectal liver metastasis patients qualify for liver transplant, but HAIP chemotherapy can improve outcomes.

• Only 4.8% of patients in the study were liver transplant-eligible.
• After HAIP, the median overall survival was 61 months, with a 5-year survival rate of 53%.

This suggests that HAIP may aid in patient selection for surgical interventions.

• 78% of patients converted to resection after a median of 5 HAIP cycles.